CARD11基因非经典区域突变所致免疫缺陷2例的临床和免疫特征

doi:10.3969/j.issn.1673-5501.2021.02.012

摘要/Abstract

摘要： 目的报道2例CARD11基因非经典区域突变所致免疫缺陷的临床和免疫特征。方法总结2例CARD11突变患儿的临床特征;采用全外显子组测序及Sanger测序技术寻找其基因突变,采用体外实验进行致病性验证,探讨其致病机制;采用流式细胞术等技术分析其免疫特征。结果 2例患儿均表现为反复呼吸道感染和过敏性疾病。例1主要表现为反复扁桃体炎、支气管炎,变应性鼻炎,发热时偶伴腹痛、关节痛;例2主要表现为反复呼吸道感染、偶发特应性皮炎及变应性结膜炎。2例均为CARD11基因杂合突变,突变位点分别为c.2542C>T(p.R848C)和c.2036A>T (p.Q679L)。c.2542C>T于2019年报道,致病机制未明;c.2036A>T既往未见报道。在293T细胞系中分别过表达携带有2种突变的CARD11蛋白,与野生型对比,2种突变蛋白对下游NF-κB通路的激活较野生型弱,提示2种突变均导致功能缺失。结论本文报告的CARD11基因突变与既往报道的经典区域突变的特征不同,丰富了CARD11基因缺陷疾病的临床和免疫特征。

关键词: CARD11缺陷, 原发性免疫缺陷病, 伴变应性皮炎的免疫缺陷病11B

Abstract: Objective To report and summarize the clinical and immune features of two patients with CARD11 mutations, which are not located in CARD domain or CC domain of the gene.Methods Two atypical CARD11 mutation patients were enrolled, and their clinical and immune features were summarized. The mutations were tested by whole exon sequencing and confirmed by Sanger sequencing. Flow cytometry was used to figure out the immune phenotypes, while in vitro experiments were performed to detect the pathogenicity and pathogenic mechanism of the mutations.Results The two patients had recurrent respiratory infection and allergic diseases. Patient 1 (P1) presented with recurrent tonsillitis, bronchopneumonia, allergic rhinitis and occasional abdominal pain or joint pain together with fever. Patient 2 (P2) presented with recurrent upper respiratory infection,occasional atopic dermatitis and allergic conjunctivitis. Both of the two patients had heterozygous mutation in the gene of CARD11 . The mutation sites were c.2542C>T (p.R848C)for P1 and c.2036A>T(p.Q679L)for P2. c.2542C>T was reported in 2019 and c.2036A>T had not been reported before. The two mutant CARD11 proteins showed less stimulation of the NF-κB signal pathway compared with WT CARD11 protein when overexpressed in 293T cells, which indicates that the mutations would lead to loss of function(LOF).Conclusion The characteristics of this novel CARD11 mutation are different from those of mutations in typical sites, which enriches the clinical and immune features of CARD11 deficiency.

Key words: CARD11 deficiency, Immunodeficiency, Immunodeficiency 11B with atopic dermatitis

李天慈, 王莹, 王文婕, 应文静, 刘璐瑶, 胡榆, 王晓川, 吕伟, 孙金峤. CARD11基因非经典区域突变所致免疫缺陷2例的临床和免疫特征[J]. 中国循证儿科杂志, 2021, 16(2): 141-145.

LI Tianci, WANG Ying, WANG Wenjie, YING Wenjing, LIU Luyao, HU Yu, WANG Xiaochuan, LYU Wei, SUN Jinqiao. The clinical and immune features of patients with CARD11 mutations located in atypic domain[J]. Chinese Journal of Evidence-Based Pediatrics, 2021, 16(2): 141-145.

参考文献

[1] Choi Y, Sims GE, Murphy S, et al. Predicting the functional effect of amino acid substitutions and indels. PLoS One, 2012, 7(10): e46688.
[2] Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 2015, 31(16): 2745-2747.
[3] Stepensky P, Keller B, Buchta M, et al. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J Allergy Clin Immunol, 2013, 131(2): 477-485.
[4] Darte JM, Mcclure PD, Saunders EF, et al. Congenital lymphoid hyperplasia with persistent hyperlymphocytosis. N Engl J Med, 1971, 284(8): 431-432.
[5] Arjunaraja S, Nose BD, Sukumar G, et al. Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-kappaB and T Cell Anergy Patient B Cells. Front Immunol, 2017, 8: 913.
[6] Snow AL, Xiao W, Stinson JR, et al. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations. J Exp Med, 2012, 209(12): 2247-2261.
[7] Arjunaraja S, Angelus P, Su HC, et al. Impaired control of Epstein-Barr virus Infection in B-cell expansion with NF-kappaB and T-cell anergy disease. Front Immunol, 2018, 9: 198.
[8] Chan W, Schaffer TB, Pomerantz JL. A quantitative signaling screen identifies CARD11 mutations in the CARD and LATCH domains that induce Bcl10 ubiquitination and human lymphoma cell survival. Mol Cell Biol, 2013, 33(2): 429-443.
[9] Greil J, Rausch T, Giese T, et al. Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. J Allergy Clin Immunol, 2013, 131(5): 1376-1383.
[10] Ma CA, Stinson JR, Zhang Y, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet, 2017, 49(8): 1192-1201.
[11] Dorjbal B, Stinson JR, Ma CA, et al. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease. J Allergy Clin Immunol, 2019, 143(4): 1482-1495.
[12] Buchbinder D, Stinson JR, Nugent DJ, et al. Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutation. J Allergy Clin Immunol, 2015, 136(3): 819-821.
[13] Lenz G, Davis R E, Ngo V N, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science, 2008, 319(5870): 1676-1679.
[14] Eyre TA, Martinez-Calle N, Hildyard C, et al. Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP. Br J Haematol, 2019, 186(4): e94-e98.
[15] Hedstrom G, Peterson S, Berglund M, et al. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma-a Swedish population-based study. Acta Oncol, 2015, 54(6): 924-932.